There is renewed hope a global COVID-19 vaccine could become mainstream before the end of 2020 thanks to promising results in the UK. Scientists at Oxford University have conducted early-stage clinical trials of a vaccine called AZD1222 in healthy volunteers. The results have been highly encouraging, producing antibody and T-cell immune reponses with no negative side effects. British-Swedish multinational pharmaceutical and biopharmaceutical company AstraZeneca has been working on the vaccine … Continue reading Hope for COVID-19 vaccine